Literature DB >> 11467026

Failure to vaccinate current injecting drug users against hepatitis B in England and Wales.

T L Lamagni1, V D Hope, K L Davison, J V Parry, O N Gill.   

Abstract

In most industrialised countries the elimination of hepatitis B infection is highly reliant on effective vaccine delivery to injecting drug users. This paper highlights the very poor vaccine coverage achieved in England and Wales in the ten years since this problem was officially recognised and targeted. This is despite the existence of a comprehensive and well-utilised network of specialist services for injecting drug users.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11467026

Source DB:  PubMed          Journal:  Commun Dis Public Health        ISSN: 1462-1843


  4 in total

1.  Prevalence of hepatitis and HIV infections and vaccination rates in patients entering the heroin-assisted treatment in Switzerland between 1994 and 2002.

Authors:  Miriam Gerlich; Patrick Gschwend; Ambros Uchtenhagen; Alexander Krämer; Jürgen Rehm
Journal:  Eur J Epidemiol       Date:  2006-07-21       Impact factor: 8.082

2.  Effects of a nurse-managed program on hepatitis A and B vaccine completion among homeless adults.

Authors:  Adeline Nyamathi; Yihang Liu; Mary Marfisee; Steven Shoptaw; Paul Gregerson; Sammy Saab; Barbara Leake; Darlene Tyler; Lillian Gelberg
Journal:  Nurs Res       Date:  2009 Jan-Feb       Impact factor: 2.381

3.  Hepatitis B vaccination and injecting drug users.

Authors:  John Budd; Roy Robertson; Rob Elton
Journal:  Br J Gen Pract       Date:  2004-06       Impact factor: 5.386

4.  An economic evaluation of contingency management for completion of hepatitis B vaccination in those on treatment for opiate dependence.

Authors:  Rachid Rafia; Peter J Dodd; Alan Brennan; Petra S Meier; Vivian D Hope; Fortune Ncube; Sarah Byford; Hiong Tie; Nicola Metrebian; Jennifer Hellier; Tim Weaver; John Strang
Journal:  Addiction       Date:  2016-05-06       Impact factor: 6.526

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.